Yazar "Atik, Sinem" seçeneğine göre listele

Listeleniyor 1 - 10 / 10
  • [ X ]
    Öğe
    Association between ABCB1 (MDR1) Gene 3435 C>T Polymorphism and Colchicine Unresponsiveness of FMF Patients
    (Taylor & Francis Ltd, 2011) Ozen, Filiz; Sılan, Coşkun; Uludağ, Ahmet; Candan, Ferhan; Sılan, Fatma; Ozdemir, Semra; Atik, Sinem
    The multidrug resistance gene-1 (MDR1, adenosine triphosphate-binding cassette transporter: ABCB1, P-glycoprotein) encodes membrane proteins that play a crucial role in protecting cells from xenobiotics, chemicals, and drugs. The TT genotype of 3435 codon in exon 26 of MDR1 gene causes overexpression of gene activity and effluxes many chemically diverse compounds across the plasma membrane. We studied the association between C3435T polymorphisms (single nucleotide polymorphism) of MDR1 gene and colchicine-resistant familial Mediterranean fever (FMF) patients. Total genomic DNA samples from 52 FMF patients of colchicine unresponsiveness were used for FMF (MEFV) and MDR1 genes profile analyses. Target genes were genotyped by multiplex PCR-based reverse-hybridization Strip Assay method. The preliminary current results showed increased T allele frequency (0.596) in colchicine unresponsiveness of FMF patients. The distributions of the CC, CT, and TT genotypes in colchicine nonresponder FMF patients were 17%, 46%, and 37%, respectively. Our results indicate that C3435T polymorphism in exon 26 of MDR1 gene is associated with colchicine resistance in nonresponder FMF patients during the common therapy protocol.
  • [ X ]
    Öğe
    Combined Effect of Factor V Leiden, MTHFR, and Angiotensin-Converting Enzyme (Insertion/Deletion) Gene Mutations in Hypertensive Adult Individuals: A Population-Based Study from Sivas and Canakkale, Turkey
    (Mary Ann Liebert, Inc, 2011) Demirel, Yeltekin; Dogan, Sezai; Uludağ, Ahmet; Sılan, Coşkun; Atik, Sinem; Sılan, Fatma; Özdemir, Öztürk
    Background: Hypertension is one of the leading causes of mortality and morbidity in the world, which is influenced by environmental and genetic factors. The methylenetetrahydrofolate reductase (MTHFR) and angiotensin-converting enzymes (ACE) are possible candidate genes that may influence both body fatness and blood pressure (BP). The purpose of this study was to examine the carriage of gene combinations of the ACE (insertion/deletion [I/D]), MTHFR 677T and 1298C, and lipid profiles in patients with essential hypertension (EH) in Turkey. Methods: A total of 150 adult individuals (50 hypertensive, 50 first-degree relatives, and 50 healthy controls) from Sivas/Turkey with the same age and gender were assessed for body composition, lipid profiles, resting BP, and gene profiles. Additionally, 149 individuals (99 hypertensive, 50 controls) from Canakkale/Turkey had been investigated for ACE I/D polymorphism. Peripheral blood samples were genotyped using strip assay reverse-hybridization multiplex polymerase chain reaction tests for target genes. Results: Heterozygous mutation in FV Leiden was found to be higher in the hypertensive and first-degree relatives when compared with the control group (p < 0.05). Homozygous DD alleles of the ACE gene were also higher than the ACE I/D and control groups (p < 0.05). The high rates of cholesterol and low-density lipoprotein and low rates of high-density lipoprotein were found in patients with EH when compared with the control. Conclusion: Results show that ACE with DD alleles and mutated alleles of FV Leiden and MTHFR genes were significantly different between genotypes and have a combined effect on EH in Turkish population. Further studies are needed to investigate the genetics of obesity, EH, and BP phenotypes in the current adult population.
  • [ X ]
    Öğe
    Combined point mutations in codon 12 and 13 of KRAS oncogene in prostate carcinomas
    (Springer, 2012) Sılan, Fatma; Gultekin, Yener; Atik, Sinem; Kilinc, Davran; Alan, Cabir; Yildiz, Fazilet; Uludağ, Ahmet
    Prostate cancer is a common malignancy that develops by structural mutation(s) and/or other genetic alterations in specific genes.The G to T transversions in codon 12 and C to T transitions in codon 13 of KRAS proto-oncogene are predominant point mutations that occur in about 20% of different cancers in human. In the current study it was aimed to investigate the prevalence and predictive significance of KRAS mutations in patients with prostate carcinomas. In a total of 30 fresh tumoural tissue specimens were investigated in patients with prostate carcinoma. All tumoural specimens were histo-pathologically diagnosed and genotyped for codon 12, 13 KRAS point mutations by reverse hybridisation and direct sequencing methods. KRAS mutations were found in 12 (40%) samples with 29 samples deriving from adenocarcinomas and 1 sample was small cell prostate carcinoma. In 1 (3.44%) sample codon 12 was found to be mutated and in 2 (6.8%) samples codon 13 and in 9 (31%) samples combined codon 12 and 13 were found to be mutated particularly in higher grade of tumoural tissues. Our study, based on representative collection of human prostate tumours, indicates that combined mutations in codons 12 and 13 KRAS are relatively infrequent and most commonly occur in prostate carcinomas.
  • Küçük Resim
    Öğe
    Fetal anöploidi açısından yüksek riskli gebeliklerin QF-PCR ile analizi
    (Çanakkale Onsekiz Mart Üniversitesi, 2013-01) Güngör, Ayşe Nur Çakır; Hacıvelioğlu, Servet; Uludağ, Ahmet; Gencer, Meryem; Uysal, Ahmet; Atik, Sinem; Coşar, Emine; Sılan, Fatma; Özdemir, Öztürk
    [No Abstract Available]
  • [ X ]
    Öğe
    Fetal Anöploidi Açısından Yüksek Riskli Gebeliklerin QF-PCR İle Analizi
    (Çanakkale Onsekiz Mart Üniversitesi, 2013) Güngör, Ayşe Nur Çakır; Hacıvelioğlu, Servet; Uludağ, Ahmet; Gencer, Meryem; Uysal, Ahmet; Atik, Sinem; Coşar, Emine
    Kantitatif fluoresan polimeraz zincir reaksiyon (Quantitative Fluorescent Polymerase Chain Reaction, QF-PCR) yöntemi yaygın kromozom anormalliklerine yönelik yapılan düşük maliyetli, hızlı ve otomasyon sağlayan avantajlı bir prenatal tanı yöntemidir. Hastanemizde prenatal anöploidi taramasında aktif olarak kullanılmaktadır. Çalışmamızda 2011 Haziran- 2012 Temmuz ayları arasında ileri anne yaşı, ikili, üçlü yada dörtlü taramada riskli sonuç çıkan hastalar veya ailenin anksiyetesi nedeniyle başvuran hastalardan amniyosentez yapılanların dosyaları retrospektif olarak incelendi. Değerlendirilen 98 hastanın ortalama yaşı 32.98’di. Hastaların 94’ünün (%95,9) amniyosentez sonucu normal, 3’ünün (%3,1) sonucu Trisomi 21 olarak değerlendirildi. Uninformatif sonuç 1 hastada görüldü. Kliniğimizde uygun hastalarda QF-PCR ile etkin olarak amniyosentez mayiinden 13,18, 21, X ve Y kromozomları taranmaktadır
  • [ X ]
    Öğe
    GJB2 35delG and Mitochondrial A1555G Mutations and Etiology of Deafness at the Gelibolu School for the Deaf in Turkey
    (Aves, 2011) Sılan, Fatma; Guclu, Oguz; Kadioglu, Laliz Esin; Sılan, Coşkun; Atik, Sinem; Uludağ, Ahmet; Demiray, Asli
    Objective: 35delG mutation in the GJB2 (gap junction protein beta 2, connexin 26) gene is the most frequent mutation in patients with non-syndromic autosomal recessive deafness. The A1555G mutation in the mitochondrial 12S rRNA is another important genetic alteration, and is associated with aminoglycoside-induced deafness. The aim of this study was to explore the etiology of deafness and the prevalence of both mutations in the study cases. Materials and Methods: We examined audiological and dysmorphological features of all children at the Gelibolu School for the deaf. A questionnaire investigating prenatal, perinatal and postnatal etiological causes of deafness was prepared, and pedigree analysis was performed for each individual. After ENT examination, audiological tests and mutation analysis with the RT PCR method were carried out. Results: The GJB2 35delG and mitochondrial A1555G mutations were detected in 12% and 10% of all deaf school children, respectively. The percentages of genetic, acquired, both genetic and environmental, and unknown etiologies were 62.5, 20.3, 15.6 and 1.6, respectively. One patient had both Waardenburg Syndrome and the mitochondrial A1555G mutation, and one patient carried both 35delG and mitochondria! A1555G mutations. Interestingly, one sporadic case, who developed deafness after fever and aminoglycoside treatment, was found to have a homozygous 35delG mutation. His parents and healthy brother were heterozygous for the mutation. Discussion: Our results showed that dysmorphologic examination and mutation analysis are important for the clarification of etiology, and that they can be helpful for genetic counselling.
  • [ X ]
    Öğe
    Increased T allele frequency in MTHFR C677T gene in thyroid carcinoma
    (Springer, 2011) Ozdemir, Semra; Sılan, Fatma; Erselcan, Taner; Uludağ, Ahmet; Ustun, Funda; Colak, Ahmet; Atik, Sinem
    [Anstract Not Available]
  • [ X ]
    Öğe
    Increased T-Allele Frequency of 677 C > T Polymorphism in the Methylenetetrahydrofolate Reductase Gene in Differentiated Thyroid Carcinoma
    (Mary Ann Liebert, Inc, 2012) Ozdemir, Semra; Sılan, Fatma; Hasbek, Zekiye; Uludağ, Ahmet; Atik, Sinem; Erselcan, Taner; Özdemir, Öztürk
    Background: Epigenetic alterations in the global DNA methylation status may be associated with an increased risk of some cancer types in humans. The methylenetetrahydrofolate reductase (MTHFR) gene is involved in folic acid metabolism and plays an essential role in inherited DNA methylation profiles. The common 677 C > T and 1298 A > C polymorphisms in the MTHFR gene cause the production of a thermolabile enzyme with reduced function and, eventually, genomic DNA hypomethylation. The current preliminary study was designed to determine the association between germ-line polymorphism in the MTHFR gene and differentiated thyroid carcinoma (DTC). Methods: In the current case-control study of 60 thyroid carcinomas (TC); 45 papillary TC, 9 follicular TC, and 6 DTC of an uncertain malignant potential were examined. Genomic DNA was extracted from peripheral blood with EDTA, genotyped by a multiplex real-time polymerase chain reaction. Results: An elevated 2.33-fold risk was observed for DTC in individuals with the 677TT genotype when compared with the control group (odds ratio [OR]: 1.92, 95% confidence interval [CI]: 1.03-3.58). Current DTC patients showed similar results as a control group for the 1298 A > C allele. No significant risk was detected for the homozygous 1298CC genotype (CC vs. AA or AC) (OR: 1.30, 95% CI: 0.73-2.29). Conclusion: The current results are supportive of the hypothesis that the homozygous MTHFR 677TT genotype increases the risk factor of developing thyroid cancer, and further large-scale studies are needed to validate this association.
  • [ X ]
    Öğe
    Recurrent Pregnancy Loss and Its Relation to Combined Parental Thrombophilic Gene Mutations
    (Mary Ann Liebert, Inc, 2012) Özdemir, Öztürk; Yenicesu, Gonca Imir; Sılan, Fatma; Koksal, Binnur; Atik, Sinem; Ozen, Filiz; Gol, Mert
    Background and Aim: Recurrent pregnancy loss (RPL) is a heterogeneous disorder that has been associated with antiphospholipid syndrome and other prothrombotic parameters. We aimed to investigate the prevalence of 12 thrombophilic gene mutations in RPL couples in the current results. Method: In a total of 543 Turkish women with RPL and 327 of their male partners (870 individuals with RPL), and a control group of 106 fertile couples (control) were analyzed for factor V leiden (FVL), factor V H1299R, factor II prothrombin G20210A, FXIII V34L, b-fibrinogen -455G>A, plasminogen activator inhibitor-1 (PAI-1), GPIIIa L33P (HPA-1 a/b L33P), methylenetetrahydrofolate reductase (MTHFR) C677T, MTHFR A1298C, ACE I/D, Apo B R3500Q, and Apo E genes. Results: The overall, heterozygous and/or homozygous point mutations in FVL -FVR2, ApoE2, PAI-1, MTHFR C677T - A1298C, and ACE genes were associated with RPL. There was no meaningful association between RPL and other studied genes. Conclusion: The homozygosity of 4G in PAI-1 and MTHFR C677T genes in women with RPL, and heterozygosity of FVL, FVR2, ACE, and ApoE2 genes in both parents play crucial role in RPL and should be considered as a risk factor in RPL. Current results showed that RPL is related to combined parental (not only maternal) thrombophilic gene mutations.
  • [ X ]
    Öğe
    Relationship Between Response to Colchicine Treatment and MDR1 Polymorphism in Familial Mediterranean Fever Patients
    (Mary Ann Liebert, Inc, 2014) Uludağ, Ahmet; Sılan, Coşkun; Atik, Sinem; Akurut, Cisem; Uludag, Aysegul; Sılan, Fatma; Özdemir, Öztürk
    Aim: Investigate the relationship between MDR1 C3435T polymorphism and colchicine response in Familial Mediterranean fever (FMF) patients. Materials and Methods: Patients (n=50) who received colchicine regularly, were willing to participate in the study, and attended control visits were included in the study. MDR1 C3435T genotype was defined by the real-time polymerase chain reaction method. Patients were divided into three groups. Patients, who recovered from episodes with standard colchicine treatment, and had no attack in the last 1 year were accepted as complete; patients whose episode number and intensity were decreased with the ongoing standard treatment as partial; and patients whose episodes were not decreased despite the standard treatment as nonresponders. Results:MDR1 C and T allele frequencies of FMF patients with colchicine responses of complete, partial, and nonresponders were C=0.75 and T=0.25; C=0.56 and T=0.44; and C=0.50 and T=0.50, respectively. When complete responding patients were compared with the partial responding patients, subjects with CT genotype had 6.18 times more increased risk than with CC genotype (OR=6.18; p=0.015). Poor response risk of subjects with the T allele was increased 2.45 times more when compared with the C allele (p=0.03). Conclusion:MDR1 gene C3435T polymorphism enacts an important role on colchicine response in FMF; good response to colchicine treatment was related to the C allele, whereas poor response was related to the T allele in FMF.